The diagnosis of HHT is established when a suspected patient bears a pathogenic variant (‘mutation’) in ENG, ACVRL1, SMAD4, or GDF2 or presents with at least three of the four Curaçao criteria [2,3]. The gene discussed is ACVRL1; the disease is hereditary hemorrhagic telangiectasia.